Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind, placebo-controlled pilot study

Silvana Chiara, Maria Teresa Nobile, Maura Vincenti, Alberto Gozza, Ilaria Pastrone, Matteo Rosso, Riccardo Rosso

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: The study was a double-blind, placebo-controlled, randomised pilot study to assess the efficacy of sucralfate gel in the treatment of chemotherapy-induced mucositis. Patients and Methods: At the onset of stomatitis, forty patients received sucralfate gel (1 gr.) or placebo and were instructed to apply the gel over oral mucosas, 3 times daily. Results: Objective response was observed in 14 patients (11 complete response+3 partial response) and in 15 patients (10 CR + 5 PR), in the sucralfate and placebo arms, respectively; (p = NS). Analysis of VAS (visual analogue scale) scoring of pain did not detect any statistical difference between the two groups. No important side-effects were observed. Twelve out 21 patients who obtained a complete resolution of stomatitis (5 out of 11 and 7 out of 10 in the sucralfate and in placebo arms, respectively) received further treatment at the subsequent course of chemotherapy: prevention of mucositis was observed in 4 patients in the sucralfate arm and in 6 patients in the placebo arm, respectively. Conclusion: In the present pilot study, sucralfate did not demonstrate a significant advantage in comparison to the placebo in the treatment of chemotherapy-induced stomatitis.

Original languageEnglish
Pages (from-to)3707-3710
Number of pages4
JournalAnticancer Research
Volume21
Issue number5
Publication statusPublished - 2001

Fingerprint

Sucralfate
Stomatitis
Placebos
Drug Therapy
Arm
Mucositis
Gels
Therapeutics
Mouth Mucosa
Pain Measurement

Keywords

  • Chemotherapy
  • Mucositis
  • Side-effects
  • Sucralfate

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chiara, S., Nobile, M. T., Vincenti, M., Gozza, A., Pastrone, I., Rosso, M., & Rosso, R. (2001). Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind, placebo-controlled pilot study. Anticancer Research, 21(5), 3707-3710.

Sucralfate in the treatment of chemotherapy-induced stomatitis : A double-blind, placebo-controlled pilot study. / Chiara, Silvana; Nobile, Maria Teresa; Vincenti, Maura; Gozza, Alberto; Pastrone, Ilaria; Rosso, Matteo; Rosso, Riccardo.

In: Anticancer Research, Vol. 21, No. 5, 2001, p. 3707-3710.

Research output: Contribution to journalArticle

Chiara, S, Nobile, MT, Vincenti, M, Gozza, A, Pastrone, I, Rosso, M & Rosso, R 2001, 'Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind, placebo-controlled pilot study', Anticancer Research, vol. 21, no. 5, pp. 3707-3710.
Chiara, Silvana ; Nobile, Maria Teresa ; Vincenti, Maura ; Gozza, Alberto ; Pastrone, Ilaria ; Rosso, Matteo ; Rosso, Riccardo. / Sucralfate in the treatment of chemotherapy-induced stomatitis : A double-blind, placebo-controlled pilot study. In: Anticancer Research. 2001 ; Vol. 21, No. 5. pp. 3707-3710.
@article{caec788635a9409e892a8e405c749ce4,
title = "Sucralfate in the treatment of chemotherapy-induced stomatitis: A double-blind, placebo-controlled pilot study",
abstract = "Background: The study was a double-blind, placebo-controlled, randomised pilot study to assess the efficacy of sucralfate gel in the treatment of chemotherapy-induced mucositis. Patients and Methods: At the onset of stomatitis, forty patients received sucralfate gel (1 gr.) or placebo and were instructed to apply the gel over oral mucosas, 3 times daily. Results: Objective response was observed in 14 patients (11 complete response+3 partial response) and in 15 patients (10 CR + 5 PR), in the sucralfate and placebo arms, respectively; (p = NS). Analysis of VAS (visual analogue scale) scoring of pain did not detect any statistical difference between the two groups. No important side-effects were observed. Twelve out 21 patients who obtained a complete resolution of stomatitis (5 out of 11 and 7 out of 10 in the sucralfate and in placebo arms, respectively) received further treatment at the subsequent course of chemotherapy: prevention of mucositis was observed in 4 patients in the sucralfate arm and in 6 patients in the placebo arm, respectively. Conclusion: In the present pilot study, sucralfate did not demonstrate a significant advantage in comparison to the placebo in the treatment of chemotherapy-induced stomatitis.",
keywords = "Chemotherapy, Mucositis, Side-effects, Sucralfate",
author = "Silvana Chiara and Nobile, {Maria Teresa} and Maura Vincenti and Alberto Gozza and Ilaria Pastrone and Matteo Rosso and Riccardo Rosso",
year = "2001",
language = "English",
volume = "21",
pages = "3707--3710",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Sucralfate in the treatment of chemotherapy-induced stomatitis

T2 - A double-blind, placebo-controlled pilot study

AU - Chiara, Silvana

AU - Nobile, Maria Teresa

AU - Vincenti, Maura

AU - Gozza, Alberto

AU - Pastrone, Ilaria

AU - Rosso, Matteo

AU - Rosso, Riccardo

PY - 2001

Y1 - 2001

N2 - Background: The study was a double-blind, placebo-controlled, randomised pilot study to assess the efficacy of sucralfate gel in the treatment of chemotherapy-induced mucositis. Patients and Methods: At the onset of stomatitis, forty patients received sucralfate gel (1 gr.) or placebo and were instructed to apply the gel over oral mucosas, 3 times daily. Results: Objective response was observed in 14 patients (11 complete response+3 partial response) and in 15 patients (10 CR + 5 PR), in the sucralfate and placebo arms, respectively; (p = NS). Analysis of VAS (visual analogue scale) scoring of pain did not detect any statistical difference between the two groups. No important side-effects were observed. Twelve out 21 patients who obtained a complete resolution of stomatitis (5 out of 11 and 7 out of 10 in the sucralfate and in placebo arms, respectively) received further treatment at the subsequent course of chemotherapy: prevention of mucositis was observed in 4 patients in the sucralfate arm and in 6 patients in the placebo arm, respectively. Conclusion: In the present pilot study, sucralfate did not demonstrate a significant advantage in comparison to the placebo in the treatment of chemotherapy-induced stomatitis.

AB - Background: The study was a double-blind, placebo-controlled, randomised pilot study to assess the efficacy of sucralfate gel in the treatment of chemotherapy-induced mucositis. Patients and Methods: At the onset of stomatitis, forty patients received sucralfate gel (1 gr.) or placebo and were instructed to apply the gel over oral mucosas, 3 times daily. Results: Objective response was observed in 14 patients (11 complete response+3 partial response) and in 15 patients (10 CR + 5 PR), in the sucralfate and placebo arms, respectively; (p = NS). Analysis of VAS (visual analogue scale) scoring of pain did not detect any statistical difference between the two groups. No important side-effects were observed. Twelve out 21 patients who obtained a complete resolution of stomatitis (5 out of 11 and 7 out of 10 in the sucralfate and in placebo arms, respectively) received further treatment at the subsequent course of chemotherapy: prevention of mucositis was observed in 4 patients in the sucralfate arm and in 6 patients in the placebo arm, respectively. Conclusion: In the present pilot study, sucralfate did not demonstrate a significant advantage in comparison to the placebo in the treatment of chemotherapy-induced stomatitis.

KW - Chemotherapy

KW - Mucositis

KW - Side-effects

KW - Sucralfate

UR - http://www.scopus.com/inward/record.url?scp=0035570216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035570216&partnerID=8YFLogxK

M3 - Article

C2 - 11848548

AN - SCOPUS:0035570216

VL - 21

SP - 3707

EP - 3710

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5

ER -